Related Experiment Video
Updated: Aug 12, 2026
14:25
Synthesis of a Deuterated Standard for the Quantification of 2-Arachidonoylglycerol in Caenorhabditis elegans
Published on: September 21, 2019
The endocannabinoid nervous system: unique opportunities for therapeutic intervention
1Neuroscience Division, Drop 0510, Lilly Research Laboratories, Indianapolis, IN 46285, USA.
Pharmacology & Therapeutics
|July 13, 2001
Summary
Delta(9)-tetrahydrocannabinol (THC), a compound in marijuana, shows therapeutic potential for various conditions by interacting with cannabinoid receptors. Understanding the endocannabinoid system offers new avenues for developing safer and more effective cannabinoid-based medicines.
Area of Science:
- Neuroscience
- Pharmacology
- Molecular Biology
Background:
- Delta(9)-tetrahydrocannabinol (THC), the active component of marijuana, exhibits significant therapeutic potential for conditions such as pain, anxiety, and nausea.
- THC interacts with two primary cannabinoid receptors, CB1 and CB2, which are present in mammalian tissues.
- Current therapeutic strategies have largely centered on the CB1 receptor due to its high concentration in the central nervous system (CNS).
Purpose of the Study:
- To review the basic biology of the endocannabinoid nervous system.
- To explore novel therapeutic intervention opportunities based on current understanding.
- To facilitate the development of cannabinoid receptor-targeted therapeutics with enhanced safety and efficacy.
Main Methods:
- Review of existing literature on cannabinoid receptor function and endocannabinoid system biology.
- Analysis of the therapeutic applications and side effect profiles of nonselective cannabinoid agonists.
- Examination of recent findings on anandamide biosynthesis, release, transport, and disposition.
Main Results:
- Nonselective cannabinoid agonists, including THC, demonstrate therapeutic efficacy but can cause psychotropic side effects.
- The endocannabinoid system, involving lipid transmitters like anandamide, plays a crucial role in the CNS.
- Understanding the endocannabinoid system provides insights into receptor-specific targeting.
Conclusions:
- Targeting cannabinoid receptors offers promising therapeutic avenues for various medical conditions.
- Further research into the endocannabinoid system can lead to the development of more selective and safer cannabinoid-based drugs.
- Future therapeutics may offer improved efficacy and reduced side effects compared to current nonselective agonists.
Related Concept Videos
01:15G Protein-coupled Receptors
G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
01:26Neurochemical Transmission: Sites of Drug Action
Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...
01:24CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its effects by...
01:22Opioid Receptors: Overview
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2, D-Pen5]-enkephalin or DPDPE for...
01:25Analgesia and Pain Management
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
01:21Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...